Sign in Subscribe

Research

A collection of 5 issues

LL-37: The Body's Natural Antimicrobial Defense Peptide

LL-37: The Body's Natural Antimicrobial Defense Peptide Key Takeaways - LL-37 is the only human cathelicidin peptide, naturally produced by immune cells to fight infections - Research shows antimicrobial activity against bacteria, viruses, and fungi at concentrations of 2-50 μg/mL - Clinical studies suggest potential for wound

Epitalon: The Telomerase-Activating Peptide for Cellular Longevity

Epitalon: The Telomerase-Activating Peptide for Cellular Longevity Key Takeaways - Epitalon is a synthetic tetrapeptide that research suggests can activate telomerase enzyme activity - Studies indicate it may extend lifespan in animal models by 12-27% through telomere lengthening - Commonly administered at 5-10mg daily for 10-20 day cycles, typically twice

Semax: The Russian Cognitive Enhancement Peptide Backed by Decades of Research

Semax: The Russian Cognitive Enhancement Peptide Backed by Decades of Research Key Takeaways - Semax is a synthetic heptapeptide developed in Russia that enhances memory, focus, and provides neuroprotection through BDNF upregulation - Research suggests cognitive benefits at doses of 300-600 mcg daily, with effects typically observed within 1-2 weeks

Selank: The Nootropic Peptide for Anxiety and Cognition

selank-the-nootropic-peptide-for-anxiety-and-cognition">Selank: The Nootropic Peptide for Anxiety and Cognition Key Takeaways - Selank is a synthetic heptapeptide derived from tuftsin that modulates GABA and serotonin systems - Research suggests 250-300 mcg daily doses improve anxiety symptoms without sedation - Studies show cognitive enhancement effects lasting 7-10 days after

NAD+ and Peptide Therapy: The Cellular Longevity Revolution

NAD+ and Peptide Therapy: The Cellular Longevity Revolution Key Takeaways - NAD+ levels decline by approximately 50% between ages 20 and 60, impacting cellular energy production and DNA repair - Peptide-based NAD+ precursors show superior bioavailability compared to oral supplements in clinical studies - Research suggests NAD+ therapy may support